Dear Teratology Society Members:
We want to share with you the exciting news about the formal merger of Birth Defects Research (BDR) into a single journal. Many of you heard about this at the annual business meeting, but for the rest of you, here is the rationale, and some details on the merged journal.
When we formed BDR in 2002, the original intent was to have a single journal with multiple parts that fully covered the broad range of interests of the Teratology Society: genetics, dysmorphology, toxicology, developmental biology, epidemiology, and more. We believe that we have met the goal of providing a publication that fully represents teratology as an interdisciplinary science. However, the three parts of the journal have operated more or less independently, with each having its own production schedule, which means each editor faces regular deadlines without the possibility of help from the others. More importantly, ISI, the indexing service that publishes impact factors, decided early on that these were three separate journals and assigned each its own impact factor. We have been working with the publisher for several years now to develop a plan that keeps all the aspects of BDR that we value but will allow us to more fully achieve everything we set out to do with the journal. This resulted in the plan to formally consider the journal as a single entity.
What will change?
First, there will be a single website for manuscript submission. You will still be asked to select whether you would like your paper considered for the Clinical and Molecular section or the Developmental and Reproductive Toxicology section, and the appropriate editor will handle the review. (Embryo Today will continue to have all invited reviews, so this will be an option only for authors who have been invited to submit there.)
Second, we will be publishing 20 issues per year of Birth Defects Research, rather than 12 issues of part A, 6 of part B and 4 of part C. The total number of pages will remain the same. While this is only a small change in the number of issues, and no change in the number of papers published, the new schedule provides us with much more flexibility, especially in being able to offer content from each part more quickly, and in publishing complementary material together, regardless of whether it is toxicology, genetics, etc.
What won’t change?
The subscription cost will not change. The overall aims and scope will not change. The number and types of articles we publish will not change. The royalties to the Teratology Society will not change. We will continue to have separate editors for Clinical and Molecular Teratology, Developmental and Reproductive Toxicology, and Embryo Today. Michel Vekemans will serve as the coordinating editor for Birth Defects Research, but George Daston and Rocky Tuan will still operate with autonomy in their areas and the three editors will work together in assembling content.
When will this happen?
The merged journal will officially start in January 2017. Wiley is scheduled to have a test version of the combined website by September 2016. The current websites will remain operational until we are certain that the new site meets our needs.
Please feel free to reply to this email with your comments and questions.
As always, we encourage member submissions to the journal. Please visit the Society’s website for details:http://www.teratology.org/birthdefects.asp
Sonja Rasmussen, President
Norbert Makori, Chair, Publications Committee
Michel Vekemans, George Daston, Rocky Tuan, Editors